Regulus Therapeutics Inc. (RGLS)

NASDAQ: RGLS · Real-Time Price · USD

2.550

+0.230 (9.91%)

At close: Apr 23, 2025, 4:00 PM

2.700

+0.150 (5.88%)

Pre-market: Apr 24, 2025, 5:35 AM EDT

Regulus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 23, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	169	103	26	23	46	90	Upgrade
Market Cap Growth	299.81%	299.81%	12.20%	-49.82%	-49.09%	384.92%	Upgrade
Enterprise Value	94	17	-1	-15	19	87	Upgrade
Last Close Price	2.55	1.58	1.28	1.37	3.15	13.50	Upgrade
PS Ratio	-	-	-	-	-	9.03	Upgrade
PB Ratio	2.19	1.35	1.22	0.69	0.84	3.47	Upgrade
P/TBV Ratio	2.21	1.36	1.22	0.69	0.84	3.49	Upgrade
EV/Sales Ratio	-	-	-	-	-	8.67	Upgrade
Debt / Equity Ratio	0.01	0.01	0.15	0.21	0.14	0.20	Upgrade
Asset Turnover	-	-	-	-	-	0.25	Upgrade
Inventory Turnover	10.88	10.88	7.03	6.12	5.63	4.24	Upgrade
Quick Ratio	10.11	10.11	2.79	3.36	11.55	2.73	Upgrade
Current Ratio	10.98	10.98	3.31	3.78	12.48	3.17	Upgrade
Return on Equity (ROE)	-95.00%	-95.00%	-110.27%	-64.19%	-68.67%	-68.33%	Upgrade
Return on Assets (ROA)	-54.42%	-54.42%	-50.20%	-30.65%	-32.78%	-22.20%	Upgrade
Return on Capital (ROIC)	-61.47%	-61.47%	-60.28%	-34.32%	-37.07%	-26.45%	Upgrade
Earnings Yield	-27.44%	-44.80%	-116.04%	-122.76%	-60.48%	-17.42%	Upgrade
FCF Yield	-24.87%	-40.60%	-105.78%	-112.20%	-53.02%	-13.88%	Upgrade
Buyback Yield / Dilution	-197.18%	-197.18%	-24.25%	-78.07%	-145.01%	-102.65%	Upgrade

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q